Literature DB >> 23439309

Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Tiffany Weinkopff1, Anita Mariotto, Gregoire Simon, Yazmin Hauyon-La Torre, Floriane Auderset, Steffen Schuster, Haroun Zangger, Nicolas Fasel, Aldina Barral, Fabienne Tacchini-Cottier.   

Abstract

Infection with Leishmania braziliensis causes cutaneous or mucocutaneous leishmaniasis in humans. Toll-like receptor 9 (TLR9) expression has been found in granulomas of lesions in L. braziliensis-infected individuals. L. braziliensis inoculation in mice induces very small lesions that are self-healing, whereas deficiency in the TLR adaptor molecule, MyD88, renders mice susceptible to infection. The TLR involved has not been identified, prompting us to investigate if TLR9 triggering by the parasite contributes to the strong resistance to infection observed in L. braziliensis-inoculated mice. The parasites activated wild-type (WT) dendritic cells (DCs) in vitro but not DCs derived from TLR9(-/-) mice. TLR9(-/-) mice inoculated with L. braziliensis exhibited a transient susceptibility characterized by increased lesion size and parasite burden compared to those of WT mice. Surprisingly, elevated levels of gamma interferon (IFN-γ) were measured at the site of infection and in draining lymph node T cells of TLR9(-/-) mice at the peak of susceptibility, suggesting that unlike observations in vitro, the parasite could induce DC activation leading to the development of Th1 cells in the absence of TLR9 expression. Taken together, these data show that TLR9 signaling is important for the early control of lesion development and parasite burden but is dispensable for the differentiation of Th1 cells secreting IFN-γ, and the high levels of this cytokine are not sufficient to control early parasite replication following L. braziliensis infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23439309      PMCID: PMC3648021          DOI: 10.1128/IAI.01401-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  The MyD88 protein 88 pathway is differently involved in immune responses induced by distinct substrains of Leishmania major.

Authors:  Mélanie Revaz-Breton; Catherine Ronet; Annette Ives; Yazmin Hauyon-La Torre; Slavica Masina; Fabienne Tacchini-Cottier; Pascal Launois
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

2.  Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns.

Authors:  Maria Jania Teixeira; Juliana Dumet Fernandes; Clarissa Romero Teixeira; Bruno Bezerril Andrade; Margarida Lima Pompeu; João Santana da Silva; Cláudia Ida Brodskyn; Manoel Barral-Netto; Aldina Barral
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 3.  Mucosal leishmaniasis ("espundia" Escomel, 1911).

Authors:  P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

4.  Leishmania major infection in C57BL/10 mice differing at the Lps locus: a new non-healing phenotype.

Authors:  I Müller; M Freudenberg; P Kropf; A F Kiderlen; C Galanos
Journal:  Med Microbiol Immunol       Date:  1997-10       Impact factor: 3.402

Review 5.  Cutaneous leishmaniasis.

Authors:  Richard Reithinger; Jean-Claude Dujardin; Hechmi Louzir; Claude Pirmez; Bruce Alexander; Simon Brooker
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

6.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

Authors:  E M Carvalho; W D Johnson; E Barreto; P D Marsden; J L Costa; S Reed; H Rocha
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

7.  Cytokine patterns in the pathogenesis of human leishmaniasis.

Authors:  C Pirmez; M Yamamura; K Uyemura; M Paes-Oliveira; F Conceição-Silva; R L Modlin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.

Authors:  F Janaina Soares Rocha; Ulrike Schleicher; Jochen Mattner; Gottfried Alber; Christian Bogdan
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

9.  Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice.

Authors:  Diego A Vargas-Inchaustegui; Wendy Tai; Lijun Xin; Alison E Hogg; David B Corry; Lynn Soong
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

10.  Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.

Authors:  P Kropf; N Freudenberg; C Kalis; M Modolell; S Herath; C Galanos; M Freudenberg; I Müller
Journal:  J Leukoc Biol       Date:  2004-03-23       Impact factor: 4.962

View more
  23 in total

1.  Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis.

Authors:  Diego L Costa; Luiz H Guimarães; Thiago M Cardoso; Adriano Queiroz; Ednaldo Lago; Ana M Roselino; Olívia Bacellar; Edgar M Carvalho; João S Silva
Journal:  Hum Immunol       Date:  2013-08-28       Impact factor: 2.850

Review 2.  The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Authors:  Mary-Anne Hartley; Stefan Drexler; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Trends Parasitol       Date:  2014-06-20

3.  Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease.

Authors:  Tiffany Weinkopff; Christoph Konradt; David A Christian; Dennis E Discher; Christopher A Hunter; Phillip Scott
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

Review 4.  Redundant and regulatory roles for Toll-like receptors in Leishmania infection.

Authors:  P Chauhan; D Shukla; D Chattopadhyay; B Saha
Journal:  Clin Exp Immunol       Date:  2017-08-07       Impact factor: 4.330

Review 5.  Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis.

Authors:  Ciro Martins Gomes; Suleimy Cristina Mazin; Elisa Raphael dos Santos; Mariana Vicente Cesetti; Guilherme Albergaria Brízida Bächtold; João Henrique de Freitas Cordeiro; Fabrício Claudino Estrela Terra Theodoro; Fabiana dos Santos Damasco; Sebastián Andrés Vernal Carranza; Adriana de Oliveira Santos; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-03-31       Impact factor: 2.743

6.  Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection.

Authors:  Laís Sacramento; Silvia C Trevelin; Manuela S Nascimento; Djalma S Lima-Jùnior; Diego L Costa; Roque P Almeida; Fernando Q Cunha; João S Silva; Vanessa Carregaro
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

7.  Do you see what I see: Recognition of protozoan parasites by Toll-like receptors.

Authors:  Debopam Ghosh; Jason S Stumhofer
Journal:  Curr Immunol Rev       Date:  2013-08

8.  TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection.

Authors:  Ismael P Sauter; Katerine G Madrid; Josiane B de Assis; Anderson Sá-Nunes; Ana C Torrecilhas; Daniela I Staquicini; Renata Pasqualini; Wadih Arap; Mauro Cortez
Journal:  JCI Insight       Date:  2019-05-16

9.  Enhanced expression of Toll-like receptors 2 and 4, but not 9, in spleen tissue from patients with visceral leishmaniasis.

Authors:  R Kumar; O P Singh; S Gautam; S Nylen; S Sundar
Journal:  Parasite Immunol       Date:  2014-12       Impact factor: 2.280

Review 10.  Innate immunity against Leishmania infections.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Cell Microbiol       Date:  2015-08-11       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.